Submitted by Anonymous (not verified) on 21 January 2026 - 15:02
Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 8, Status: Authorised